Arthrochalasis Type of Ehlers-Danlos Syndrome (EDS Types VIIA and VIIB) and Related Disorders - Osteogenesis Imperfecta - page 205

involve exon 6 in the COL1A1 and COL1A2 genes of type I col-
lagen. Am J Med Genet 1997;72(1):94-105.
[8] Chiodo AA, Hockey A, Cole WG. A base substitution at the
splice acceptor site of intron 5 of the COL1A2 gene activates a
cryptic splice site within exon 6 and generates abnormal type I
procollagen in a patient with Ehlers-Danlos syndrome type VII.
J Biol Chem 1992;267(9):6361-9.
[9] Carr AJ, Chiodo AA, Hilton JM, Chow CW, Hockey A, Cole
WG. The clinical features of Ehlers-Danlos syndrome type VIIB
resulting from a base substitution at the splice acceptor site of
intron 5 of the COL1A2 gene. J Med Genet 1994;31(4):306-11.
[10] Weil D, D'Alessio M, Ramirez F, Steinmann B, Wirtz MK, Glanville
RW, et al. Temperature-dependent expression of a collagen splic-
ing defect in the ibroblasts of a patient with Ehlers-Danlos syn-
drome type VII. J Biol Chem 1989;264(28):16804-9.
[11] Giunta C, Superti-Furga A, Spranger S, Cole WG, Steinmann B.
Ehlers-Danlos syndrome type VII: clinical features and molecu-
lar defects. J Bone Joint Surg Am 1999;81(2):225-38.
[12] Vasan NS, Kuivaniemi H, Vogel BE, Minor RR, Wootton JA,
Tromp G, et al. A mutation in the pro alpha 2(I) gene (COL1A2)
for type I procollagen in Ehlers-Danlos syndrome type VII:
evidence suggesting that skipping of exon 6 in RNA splicing
may be a common cause of the phenotype. Am J Hum Genet
1991;48(2):305-17.
[13] Minor RR, Sippola-Thiele M, McKeon J, Berger J, Prockop DJ.
Defects in the processing of procollagen to collagen are demon-
strable in cultured ibroblasts from patients with the Ehlers-
Danlos and osteogenesis imperfecta syndromes. J Biol Chem 1986;
261(21):10006-14.
[14] Nicholls AC, Oliver J, Renouf DV, McPheat J, Palan A, Pope
FM. Ehlers-Danlos syndrome type VII: a single base change
that causes exon skipping in the type I collagen alpha 2(I) chain.
Hum Genet 1991;87(2):193-8.
[15] Pope FM, Nicholls AC, Palan A, Kwee ML, De Groot WP,
Hausmann R. Clinical features of an affected father and daugh-
ter with Ehlers-Danlos syndrome type VIIB. Br J Dermatol 1992;
126(1):77-82.
[16] Eyre DR, Shapiro FD, Aldridge JF. A heterozygous collagen
defect in a variant of the Ehlers-Danlos syndrome type VII.
Evidence for a deleted amino-telopeptide domain in the pro-
alpha 2(I) chain. J Biol Chem 1985;260(20):11322-9.
[17] Weil D, D'Alessio M, Ramirez F, de Wet W, Cole WG, Chan D, et al.
A base substitution in the exon of a collagen gene causes alterna-
tive splicing and generates a structurally abnormal polypep-
tide in a patient with Ehlers-Danlos syndrome type VII. EMBO J
1989;8(6):1705-10.
[18] Giovannucci Uzielli ML, Giunta C, Scarselli G, Dayan N, lapi E Di
Medio L. A seven years follow-up of a new case of Ehelrs-Danlos
syndrome type VIIB: major problems are represented by bilateral,
extremely severe hip dislocation. (Program Nr. 1018W) Presented
at the 12th International Congress of Human Genetics/61st Annual
Meeting of the American Society of Human Genetics, October 12,
2011, Montreal, Canada.

patients with Ehlers-Danlos syndrome type VII. J Med Genet
2000;37(11):E33.
[23] Wirtz MK, Keene DR, Hori H, Glanville RW, Steinmann B,
Rao VH, et al. In vivo and in vitro noncovalent association of
excised alpha 1 (I) amino-terminal propeptides with mutant pN
alpha 2(I) collagen chains in native mutant collagen in a case of
Ehlers-Danlos syndrome, type VII. J Biol Chem 1990;265(11):
6312-7.
[24] Weil D, Bernard M, Combates N, Wirtz MK, Hollister DW,
Steinmann B, et al. Identiication of a mutation that causes exon
skipping during collagen pre-mRNA splicing in an Ehlers-
Danlos syndrome variant. J Biol Chem 1988;263(18):8561-4.
[25] Wirtz MK, Glanville RW, Steinmann B, Rao VH, Hollister DW.
Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids
comprising the N-telopeptide region of a pro-alpha 2(I) chain. J
Biol Chem 1987;262(34):16376-85.
[26] Ho KK, Kong RY, Kuffner T, Hsu LH, Ma L, Cheah KS. Further
evidence that the failure to cleave the aminopropeptide of type I
procollagen is the cause of Ehlers-Danlos syndrome type VII. Hum
Mutat 1994;3(4):358-64.
[27] Giunta CSB. Gene symbol: COL1A2. Disease: Ehlers-Danlos
syndrome type VIIB. Hum Genet 2008;123(5):540.
[28] Klaassens M, Reinstein E, Hilhorst-Hofstee Y, Schrander J,
Malfait F, Staal H, et al. Ehlers-Danlos arthrochalasia type
(VIIA-B) - expanding the phenotype: from prenatal life through
adulthood. Clin Genet 2012;82(2):121-30.
[29] Hudgins LCC, Drummond-Borg LM, Atkinson M, Schwarze
U, Byers PH. Clinical and molecular indings in Ehlers-
Danlos Syndrome type VIIA. Am J Hum Genet 1999;
65(Suppl):A6.
[30] Neumann T, Eigel A, Horst J, Kennerknecht I, Steinmann B.
Expansion of clinical features in Ehlers-Danlos syndrome type
VIIA with a newly recognized COL1A1 mutation. (Program Nr.
P0424) Presented at the 10th International Congress of Human
Genetics/European Human Genetics Conference, May 15-19, 2001,
Vienna, Austria.

[31] D'Alessio M, Ramirez F, Blumberg BD, Wirtz MK, Rao VH,

Godfrey MD, et al. Characterization of a COL1A1 splicing defect
in a case of Ehlers-Danlos syndrome type VII: further evidence of
molecular homogeneity. Am J Hum Genet 1991;49(2):400-6.

[32] Cole WG, Chan D, Chambers GW, Walker ID, Bateman JF.

Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I
procollagen in a patient with the Ehlers-Danlos syndrome type
VII. J Biol Chem 1986;261(12):5496-503.

[33] Cole WG, Evans R, Sillence DO. The clinical features of Ehlers-

Danlos syndrome type VII due to a deletion of 24 amino acids
from the pro alpha 1(I) chain of type I procollagen. J Med Genet
1987;24(11):698-701.

[34] Bateman JF, Golub SB. Assessment of procollagen processing

defects by ibroblasts cultured in the presence of dextran sul-
phate. Biochem J 1990;267(3):573-7.

[35] Giunta C, Chambaz C, Pedemonte M, Scapolan S, Steinmann B.

The arthrochalasia type of Ehlers-Danlos syndrome (EDS VIIA
and VIIB): the diagnostic value of collagen ibril ultrastructure.
Am J Med Genet A 2008;146A(10):1341-6.

[19] Lehmann HW, Mundlos S, Winterpacht A, Brenner RE, Zabel B,

Muller PK. Ehlers-Danlos syndrome type VII: phenotype and
genotype. Arch Dermatol Res 1994;286(8):425-8. [36] McKusick V. The Ehlers-Danlos syndrome. Heritable disorders

of connective tissue. St. Louis: CV Mosby; 1972. p. 292-371. [20] Viljoen D, Goldblatt J, Thompson D, Beighton P. Ehlers-Danlos

syndrome: yet another type? Clin Genet 1987;32(3):196-201. [37] Colige A, Nuytinck L, Hausser I, van Essen AJ, Thiry M,

Herens C, et al. Novel types of mutation responsible for the
dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC)
and common polymorphisms in the ADAMTS2 gene. J Invest
Dermatol 2004;123(4):656-63.

[21] Watson RB, Wallis GA, Holmes DF, Viljoen D, Byers PH, Kadler

KE. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of
abnormal type I procollagen by N-proteinase in vitro results in the
formation of copolymers of collagen and partially cleaved pNcol-
lagen that are near circular in cross-section. J Biol Chem 1992;
267(13):9093-100.

[38] Raghunath M, Steinmann B, Delozier-Blanchet C, Extermann P,

Superti-Furga A. Prenatal diagnosis of collagen disorders by
direct biochemical analysis of chorionic villus biopsies. Pediatr
Res 1994;36(4):441-8.

[22] Nicholls AC, Sher JL, Wright MJ, Oley C, Mueller RF, Pope FM.

Clinical phenotypes and molecular characterisation of three